Prevalence of obesity-related multimorbidity and its health care costs among adults in the United States

The prevalence of obesity-related multimorbidity increased with increasing weight classes within age groups. Obesity-related multimorbidity presented at an earlier age with higher weight class, such that the predicted probability of having obesity-related multimorbidity was more than a decade younger in class 2 and class 3 obesity compared with overweight. It was associated with increased HCRU and higher-than-expected costs exceeding the sum for the ORCs. Early diagnosis and treatment of obesity may be needed to prevent or delay the onset of obesity-related multimorbidity and limit its associated health care costs.

Authors

Institutions

Publication Details

Journal
Journal of Managed Care & Specialty Pharmacy
Published
2025-02-01
DOI
https://doi.org/10.18553/jmcp.2025.31.2.179
Citations
4
Primary Topic
Chronic Disease Management Strategies
Type
article
Field-Weighted Citation Impact
5.42
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prevalence of obesity-related multimorbidity and its health care costs among adults in the United States

Clare J. Lee, Gerhardt Pohl, Julia P. Dunn, Xiaohong Li et al.
4 citations
Journal of Managed Care & Specialty Pharmacy
Chronic Disease Management Strategies
5.42
article

Prevalence of obesity-related multimorbidity and its health care costs among adults in the United States

Clare J. Lee, Gerhardt Pohl, Julia P. Dunn, Xiaohong Li, Hui Wang, Kyrian Ezendu
article en
4 citations

Abstract

The prevalence of obesity-related multimorbidity increased with increasing weight classes within age groups. Obesity-related multimorbidity presented at an earlier age with higher weight class, such that the predicted probability of having obesity-related multimorbidity was more than a decade younger in class 2 and class 3 obesity compared with overweight. It was associated with increased HCRU and higher-than-expected costs exceeding the sum for the ORCs. Early diagnosis and treatment of obesity may be needed to prevent or delay the onset of obesity-related multimorbidity and limit its associated health care costs.

Journal of Managed Care & Specialty PharmacyVol. 31(2)
Eli Lilly (United States) (US)
Zero hunger
Openalex Percentile: Top 5%
Chronic Disease Management Strategies
5.42
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.